RPS issues call for evidence on self-selection of P meds

Profession news

RPS issues call for evidence on self-selection of P meds

The Royal Pharmaceutical Society is asking for evidence on the facilitated self-selection of Pharmacy medicines. 

The call for evidence is open until September 6 and is the outcome of the national Pharmacy Boards meeting in June, which discussed the current RPS position that pharmacy-only medicines must not be accessible to the public by self-selection.

The RPS is asking for evidence of the benefits and harms of a facilitated self-selection model for Pharmacy medicines and whether there are any evidence gaps with an explanation of areas where further research is required. 

RPS chief executive Paul Bennett said: “Following changes brought by the GPhC focusing on an outcomes approach to standards, [the regulator] has confirmed it no longer prohibits facilitated self-selection of P medicines. As a result, there are pharmacies that are now adopting a more flexible interpretation to providing this group of medicines.”

The GPhC has stated that the sale and supply of a P medicine must still take place in a registered pharmacy premises under the supervision of a pharmacist and that appropriate measures should be in place to ensure that supervision continues, he added.

“The evidence base gathered through this exercise will inform a report by RPS Science and Research that will enable us to consider our current position,” said Mr Bennett. 

To inform the review, the RPS wants to hear from a wide range of pharmacists and pharmacy team members, patient representative bodies, employers, academics, thinktanks, pharmacy representative bodies, regulators and other stakeholders and researchers.

Copy Link copy link button

Profession news

Share: